MAP1A
Basic information
Region (hg38): 15:43510958-43531620
Previous symbols: [ "MAP1L" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
- Neurodevelopmental disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the MAP1A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 9 | |||||
missense | 153 | 161 | ||||
nonsense | 1 | |||||
start loss | 0 | |||||
frameshift | 1 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 1 | 0 | 155 | 15 | 2 |
Variants in MAP1A
This is a list of pathogenic ClinVar variants found in the MAP1A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
15-43521483-G-A | not specified | Uncertain significance (May 18, 2022) | ||
15-43521640-A-G | not specified | Uncertain significance (Feb 10, 2023) | ||
15-43521859-C-T | not specified | Uncertain significance (Dec 13, 2023) | ||
15-43521884-C-G | not specified | Uncertain significance (Nov 29, 2021) | ||
15-43521922-G-A | not specified | Uncertain significance (Oct 12, 2022) | ||
15-43521967-A-C | not specified | Uncertain significance (Jun 24, 2022) | ||
15-43521971-A-C | not specified | Uncertain significance (Jun 24, 2022) | ||
15-43521972-A-C | not specified | Uncertain significance (Jun 24, 2022) | ||
15-43521990-G-A | not specified | Uncertain significance (Jun 16, 2024) | ||
15-43522243-A-G | not specified | Uncertain significance (Jul 17, 2023) | ||
15-43522324-G-A | not specified | Uncertain significance (Dec 27, 2023) | ||
15-43522342-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
15-43522364-G-C | not specified | Uncertain significance (Jun 07, 2024) | ||
15-43522483-G-A | not specified | Uncertain significance (Sep 14, 2021) | ||
15-43522486-A-G | not specified | Uncertain significance (Dec 20, 2023) | ||
15-43522506-G-C | not specified | Uncertain significance (Feb 28, 2024) | ||
15-43522820-G-T | not specified | Uncertain significance (Aug 28, 2023) | ||
15-43522915-C-T | not specified | Uncertain significance (Feb 28, 2023) | ||
15-43522919-A-G | Benign/Likely benign (Mar 01, 2023) | |||
15-43522950-C-T | not specified | Uncertain significance (Jun 16, 2023) | ||
15-43522977-C-G | not specified | Uncertain significance (Feb 03, 2022) | ||
15-43523050-C-T | not specified | Uncertain significance (Dec 27, 2023) | ||
15-43523092-G-T | not specified | Uncertain significance (Feb 05, 2024) | ||
15-43523109-C-G | not specified | Uncertain significance (May 24, 2023) | ||
15-43523127-A-G | not specified | Uncertain significance (Mar 19, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
MAP1A | protein_coding | protein_coding | ENST00000300231 | 3 | 20663 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 2.74e-7 | 124826 | 0 | 21 | 124847 | 0.0000841 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.01 | 1297 | 1.52e+3 | 0.855 | 0.0000843 | 18093 |
Missense in Polyphen | 525 | 686.3 | 0.76497 | 8311 | ||
Synonymous | 1.41 | 551 | 595 | 0.926 | 0.0000312 | 5897 |
Loss of Function | 7.45 | 9 | 81.6 | 0.110 | 0.00000445 | 1091 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000189 | 0.000187 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000556 | 0.0000556 |
Finnish | 0.0000928 | 0.0000928 |
European (Non-Finnish) | 0.0000995 | 0.0000971 |
Middle Eastern | 0.0000556 | 0.0000556 |
South Asian | 0.0000981 | 0.0000980 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Structural protein involved in the filamentous cross- bridging between microtubules and other skeletal elements.;
Recessive Scores
- pRec
- 0.194
Intolerance Scores
- loftool
- 0.367
- rvis_EVS
- 1.16
- rvis_percentile_EVS
- 92.61
Haploinsufficiency Scores
- pHI
- 0.832
- hipred
- N
- hipred_score
- 0.328
- ghis
- 0.580
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.353
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | High | High | High |
Primary Immunodeficiency | High | High | High |
Cancer | High | High | High |
Mouse Genome Informatics
- Gene name
- Map1a
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); hearing/vestibular/ear phenotype; cellular phenotype;
Gene ontology
- Biological process
- microtubule cytoskeleton organization;axonogenesis;memory;associative learning;dendrite development;regulation of microtubule depolymerization;negative regulation of proteasomal ubiquitin-dependent protein catabolic process;regulation of synaptic plasticity;voluntary musculoskeletal movement;neuron cellular homeostasis;anterograde axonal protein transport;retrograde axonal protein transport;negative regulation of protein localization to microtubule;positive regulation of cellular protein localization;neuron projection maintenance;positive regulation of protein localization to cell surface
- Cellular component
- cytoplasm;cytosol;microtubule;microtubule associated complex;axon;dendrite;cell projection;neuron projection;neuronal cell body;axon initial segment;dendritic shaft;dendritic branch;synapse;primary dendrite;dendritic microtubule;axon cytoplasm
- Molecular function
- actin binding;structural molecule activity;protein binding;microtubule binding;cytoskeletal adaptor activity;tubulin binding;tau protein binding